Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Gains from Sales and Divestitures (2016 - 2018)

Balchem (BCPC) has disclosed Gains from Sales and Divestitures for 9 consecutive years, with $17000.0 as the latest value for Q3 2018.

  • On a quarterly basis, Gains from Sales and Divestitures changed N/A to $17000.0 in Q3 2018 year-over-year; TTM through Sep 2018 was $17000.0, a N/A change, with the full-year FY2017 number at $53000.0, changed N/A from a year prior.
  • Gains from Sales and Divestitures was $17000.0 for Q3 2018 at Balchem, roughly flat from $17000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $53000.0 in Q4 2017 to a low of $2000.0 in Q1 2014.
  • A 5-year average of $25583.3 and a median of $17000.0 in 2018 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: surged 400.0% in 2015, then plummeted 57.14% in 2018.
  • Balchem's Gains from Sales and Divestitures stood at $2000.0 in 2014, then soared by 2300.0% to $48000.0 in 2015, then rose by 8.33% to $52000.0 in 2016, then increased by 1.92% to $53000.0 in 2017, then plummeted by 67.92% to $17000.0 in 2018.
  • Per Business Quant, the three most recent readings for BCPC's Gains from Sales and Divestitures are $17000.0 (Q3 2018), $17000.0 (Q2 2018), and $6000.0 (Q1 2018).